#

Small caps

: 1220
Another factor is upcoming Fed rate cuts / Photo: Andreas Arnold/Picture Alliance
Small Caps·
Goldman Sachs AM eyes small caps after selloff
Envoy reported that its cochlear implant was moving forward to a clinical trial / Photo: Envoy Medical
Small Caps·
Stock of hearing implant developer Envoy surges after clinical trial of new device announced
Sonoma specializes in wound treatment / Photo: Instagram/Sonomapharmaeu
Small Caps·
Sonoma Pharmaceuticals shares plummet on disappointing earnings
VolitionRx makes tests to help diagnose diseases / Photo: Shutterstock
Small Caps·
Medical test developer VolitionRx retreats after additional stock offering announced
Innodata does business with every Magnificent Seven company / Photo: Shutterstock
Small Caps·
Innodata stock surges on record revenue growth, Big Tech client news
The demand for respiratory support is high / Photo: shutterstock
Small Caps·
Home medical services provider Viemed climbs after record earnings
Citius Pharmas first drug has received FDA approval / Photo: shutterstock
Small Caps·
Citius Pharmaceuticals stock falls despite approval of its lymphoma drug
The growth is largely driven by the company’s eyewear segment / Photo: instagram.com/kitseyecare
Small Caps·
Eyewear and contact lens retailer KITS Eyecare reports record revenue
Above Food calls its model seed to fork / Photo: Facebook/Abovefood
Small Caps·
Prairies and AI: How plant-based food manufacturer Above Food built its business
There are still hidden gems in the AI market, the Motley Fool argues / Photo: Shutterstock
Small Caps·
The Motley Fool spotlights three AI stocks ready for ‘bull run’
Equillium could get $35 million in a deal for rights to the drug / Photo: Shutterstock
Small Caps·
Maker of transplant rejection drug Equillium sees shares rise after successful trial
Byrna stock advanced initially on the news before retreating / Photo: facebook.com/byrnanation
Small Caps·
Nonlethal weapons manufacturer Byrna announces $10 million stock buyback
Load more